Fisher Wallace offers wearable medical devices for the treatment of depression, anxiety, and insomnia.
Fisher Wallace Laboratories provides wearable medical devices for the treatments of depression, anxiety, and insomnia. It manufactures portable brain stimulation devices for medical and non-medical applications. The device uses patented waveforms to gently stimulate the brain to produce serotonin and other neurochemicals responsible for healthy mood and sleep. Unlike antidepressant medication that inhibits neuronal receptors from absorbing serotonin it enables the brain to produce serotonin naturally while improving the brain's ability to regulate the limbic system.Fisher Wallace Laboratories is a U.S.-based company that was founded in 2007 by Kelly Roman.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 29, 2022 | Series Unknown | $2.50M | 1 | SHUFL Capital | — | Detail |
Nov 27, 2019 | Equity Crowdfunding | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
SHUFL Capital | Yes | Series Unknown |
Meyer Global Management | — | Equity Crowdfunding |